| Developers: | Medtronic (Medtronik) |
| Date of the premiere of the system: | February, 2018 |
2018: Announcement
On February 21, 2018 the American producer of the medical equipment Medtronic provided the infusional MiniMed Mio Advance set. The solution is intended for the patients with diabetes using an insulin pump.
The product will come to the market of Canada, Hong Kong and some countries of Europe in February-April, 2018. In other countries the device will go on sale by the end of 2018. Product cost at the time of the announcement is not reported.
According to developers, new infusional set differs in the convenient construction allowing to prepare quickly medicine for introduction and also to fix it by one hand even in are hardly accessible places (for example, at a waist). The device includes the special device for automatic and painless introduction of a catheter called "serter".
 | Our task - it is permanent to improve technologies and to implement the innovative solutions which will help patients with message diabetes full-fledged and long life, - the president of service of the help at diabetes of Medtronic company Annette Brüls says. - We already received the first positive reviews about MiniMed Mio Advance". |  |
The ConvaTec company which was absorbed in due time by Medtronic acted as the developer of new infusional set.
| | We are glad that using Medtronic Diabetes managed to start this innovation project, - the president of division of ConvaTec which is engaged in the infusional systems, John M. Lindskog said (John M. Lindskog). – Thanks to the fact that one of the world's largest producers of insulin pumps was engaged in release of the new device MiniMed Mio Advance becomes more available to patients. We hope that success of a new product will strengthen our partnership with Medtronic company and will lay the foundation for further joint projects. | |
The infusional MiniMed Mio Advance set was tested by more than 200 users in the winter of 2017. It is noted that more than 85% of the patients participating in the program of testing were satisfied with the device.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |